Literature DB >> 25511898

Parkinson disease: How reliable are prodromal indicators of Parkinson disease?

Laura Silveira-Moriyama1, Andrew J Lees2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25511898     DOI： 10.1038/nrneurol.2014.235

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  8 in total

Review 1.  Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience.

Authors:  G Webster Ross; Robert D Abbott; Helen Petrovitch; Caroline M Tanner; Lon R White
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

Review 2.  Defining at-risk populations for Parkinson's disease: lessons from ongoing studies.

Authors:  Daniela Berg; Ken Marek; George W Ross; Werner Poewe
Journal:  Mov Disord       Date:  2012-04-15       Impact factor: 10.338

3.  Up with the lark: a panoptic view of Parkinson disease.

Authors:  L Silveira-Moriyama; A J Lees
Journal:  Neurology       Date:  2011-07-13       Impact factor: 9.910

4.  An epidemiological survey of constipation in canada: definitions, rates, demographics, and predictors of health care seeking.

Authors:  P Pare; S Ferrazzi; W G Thompson; E J Irvine; L Rance
Journal:  Am J Gastroenterol       Date:  2001-11       Impact factor: 10.864

5.  Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study.

Authors:  Danna Jennings; Andrew Siderowf; Matthew Stern; John Seibyl; Shirley Eberly; David Oakes; Kenneth Marek
Journal:  Neurology       Date:  2014-10-08       Impact factor: 9.910

6.  Parkinson disease and smoking revisited: ease of quitting is an early sign of the disease.

Authors:  Beate Ritz; Pei-Chen Lee; Christina F Lassen; Onyebuchi A Arah
Journal:  Neurology       Date:  2014-09-12       Impact factor: 9.910

Review 7.  Meta-analysis of early nonmotor features and risk factors for Parkinson disease.

Authors:  Alastair J Noyce; Jonathan P Bestwick; Laura Silveira-Moriyama; Christopher H Hawkes; Gavin Giovannoni; Andrew J Lees; Anette Schrag
Journal:  Ann Neurol       Date:  2012-10-15       Impact factor: 10.422

8.  Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients.

Authors:  Alex Iranzo; Ana Fernández-Arcos; Eduard Tolosa; Mónica Serradell; José Luis Molinuevo; Francesc Valldeoriola; Ellen Gelpi; Isabel Vilaseca; Raquel Sánchez-Valle; Albert Lladó; Carles Gaig; Joan Santamaría
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240
  8 in total
  2 in total

1.  Assessment of Olfactory Function in MAPT-Associated Neurodegenerative Disease Reveals Odor-Identification Irreproducibility as a Non-Disease-Specific, General Characteristic of Olfactory Dysfunction.

Authors:  Katerina Markopoulou; Bruce A Chase; Piotr Robowski; Audrey Strongosky; Ewa Narożańska; Emilia J Sitek; Mariusz Berdynski; Maria Barcikowska; Matt C Baker; Rosa Rademakers; Jarosław Sławek; Christine Klein; Katja Hückelheim; Meike Kasten; Zbigniew K Wszolek
Journal:  PLoS One       Date:  2016-11-17       Impact factor: 3.240

2.  Chronic sleep restriction in the rotenone Parkinson's disease model in rats reveals peripheral early-phase biomarkers.

Authors:  Juliane Fagotti; Adriano D S Targa; Lais S Rodrigues; Ana Carolina D Noseda; Flávia W C Dorieux; Franciele F Scarante; Jessica L Ilkiw; Fernando M Louzada; Namrata R Chowdhury; Daan R van der Veen; Benita Middleton; Jeroen L A Pennings; Jonathan R Swann; Debra J Skene; Marcelo M S Lima
Journal:  Sci Rep       Date:  2019-02-13       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.